Stryker MAKO Purchase Could Preview Ortho’s Future
This article was originally published in The Gray Sheet
Market-leading orthopedic firms have mostly come up with incremental product updates in response to the growing tide of more technology-heavy upstarts. That is what makes Stryker’s $1.65 billion acquisition of MAKO Surgical stand out.
You may also be interested in...
Israeli firm Insightec appoints former Mako Surgical co-founder and chair as CEO, ACell taps new president and CEO, and more personnel updates from JenaValve Technology, Zeltiq and Reva Medical.
FDA Clears Stryker's Mako Robot To Treat Total Hip Replacement
Stryker advanced its robotic-assisted surgery opportunity with its 510(k) clearance to use its Mako system for total hip replacement surgeries. The large joint replacement manufacturer's long-term strategy is to make medical robotics that will be adopted by hospitals because their machines are compatible with different Stryker joints.
Stryker Bucks Trend With Strong Recon Sales
Stryker’s second-quarter sales figures paint the U.S. joint reconstruction market in a more positive light than some feared earlier in the month.